Popular Searches
Diphenyleneiodonium chlorideEpacadostatGilteritinibDinaciclibRo-3306
TargetMol | Star Product
Wikimole
TargetMol | New Product
New Product
TargetMol | Compound Library
Compound Library
Contact UsQuotation
Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Proceed to checkoutContinue shopping
TOPBioactivityChemical infoStorage&SolubilityCalculator

(4S)-N-(tert-butyldimethylsilyl)azetidin-2-one-4-carboxylic Acid

🥰Excellent
Catalog No. T206035Cas No. 82938-50-9

(4S)-N-(tert-butyldimethylsilyl)azetidin-2-one-4-carboxylic Acid is a chiral nitrogen-containing heterocyclic derivative primarily used as a pharmaceutical synthesis intermediate.

(4S)-N-(tert-butyldimethylsilyl)azetidin-2-one-4-carboxylic Acid

(4S)-N-(tert-butyldimethylsilyl)azetidin-2-one-4-carboxylic Acid

🥰Excellent
Catalog No. T206035Cas No. 82938-50-9
(4S)-N-(tert-butyldimethylsilyl)azetidin-2-one-4-carboxylic Acid is a chiral nitrogen-containing heterocyclic derivative primarily used as a pharmaceutical synthesis intermediate.
TargetMol
Product information is being updated, if you want to purchase, please click the bulk custom button.
Bulk & Custom
Questions
View More

Resource Download

Product Introduction

Bioactivity
Description
(4S)-N-(tert-butyldimethylsilyl)azetidin-2-one-4-carboxylic Acid is a chiral nitrogen-containing heterocyclic derivative primarily used as a pharmaceutical synthesis intermediate.
Chemical Properties
Molecular Weight229.35
FormulaC10H19NO3Si
Cas No.82938-50-9
Smiles[Si](C(C)(C)C)(C)(C)N1[C@H](C(O)=O)CC1=O
Storage & Solubility Information
Storage

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Sci Citations

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

(4S)N(TERTBUTYLDIMETHYLSILYL)AZETIDIN2ONE4CARBOXYLICACID
Related Tags: buy (4S)-N-(tert-butyldimethylsilyl)azetidin-2-one-4-carboxylic Acid | purchase (4S)-N-(tert-butyldimethylsilyl)azetidin-2-one-4-carboxylic Acid | (4S)-N-(tert-butyldimethylsilyl)azetidin-2-one-4-carboxylic Acid cost | order (4S)-N-(tert-butyldimethylsilyl)azetidin-2-one-4-carboxylic Acid | (4S)-N-(tert-butyldimethylsilyl)azetidin-2-one-4-carboxylic Acid chemical structure | (4S)-N-(tert-butyldimethylsilyl)azetidin-2-one-4-carboxylic Acid formula | (4S)-N-(tert-butyldimethylsilyl)azetidin-2-one-4-carboxylic Acid molecular weight
TargetMol | Logo

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.